NCT00681226View on ClinicalTrials.gov

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

August 31, 2011

Study Completion Date

January 31, 2012

Conditions

Peripheral Arterial Disease

Interventions

DRUG

Ramipril or matching placebo

10 mg Ramipril or matching placebo once daily for 6 months

Trial Locations (1)

8008

Baker Heart Research Institute, Melbourne

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayside Health

OTHER_GOV